These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 25419568)

  • 41. Intratumoral heterogeneity in a Trp53-null mouse model of human breast cancer.
    Zhang M; Tsimelzon A; Chang CH; Fan C; Wolff A; Perou CM; Hilsenbeck SG; Rosen JM
    Cancer Discov; 2015 May; 5(5):520-33. PubMed ID: 25735774
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Profiling of normal and malignant breast tissue show CD44high/CD24low phenotype as a predominant stem/progenitor marker when used in combination with Ep-CAM/CD49f markers.
    Ghebeh H; Sleiman GM; Manogaran PS; Al-Mazrou A; Barhoush E; Al-Mohanna FH; Tulbah A; Al-Faqeeh K; Adra CN
    BMC Cancer; 2013 Jun; 13():289. PubMed ID: 23768049
    [TBL] [Abstract][Full Text] [Related]  

  • 43. WNT pathway inhibitor pyrvinium pamoate inhibits the self-renewal and metastasis of breast cancer stem cells.
    Xu L; Zhang L; Hu C; Liang S; Fei X; Yan N; Zhang Y; Zhang F
    Int J Oncol; 2016 Mar; 48(3):1175-86. PubMed ID: 26781188
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The expression of stem cell protein Piwil2 and piR-932 in breast cancer.
    Zhang H; Ren Y; Xu H; Pang D; Duan C; Liu C
    Surg Oncol; 2013 Dec; 22(4):217-23. PubMed ID: 23992744
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Molecular profiling and characterization of luminal-like and basal-like in vivo breast cancer xenograft models.
    Bergamaschi A; Hjortland GO; Triulzi T; Sørlie T; Johnsen H; Ree AH; Russnes HG; Tronnes S; Maelandsmo GM; Fodstad O; Borresen-Dale AL; Engebraaten O
    Mol Oncol; 2009 Dec; 3(5-6):469-82. PubMed ID: 19713161
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Breast cancer stem cell markers CD44, CD24 and ALDH1: expression distribution within intrinsic molecular subtype.
    Ricardo S; Vieira AF; Gerhard R; Leitão D; Pinto R; Cameselle-Teijeiro JF; Milanezi F; Schmitt F; Paredes J
    J Clin Pathol; 2011 Nov; 64(11):937-46. PubMed ID: 21680574
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The mammary progenitor marker CD61/beta3 integrin identifies cancer stem cells in mouse models of mammary tumorigenesis.
    Vaillant F; Asselin-Labat ML; Shackleton M; Forrest NC; Lindeman GJ; Visvader JE
    Cancer Res; 2008 Oct; 68(19):7711-7. PubMed ID: 18829523
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Distinct breast cancer stem/progenitor cell populations require either HIF1α or loss of PHD3 to expand under hypoxic conditions.
    Iriondo O; Rábano M; Domenici G; Carlevaris O; López-Ruiz JA; Zabalza I; Berra E; Vivanco Md
    Oncotarget; 2015 Oct; 6(31):31721-39. PubMed ID: 26372732
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Expression and prognostic significance of cancer stem cell markers CD24 and CD44 in urothelial bladder cancer xenografts and patients undergoing radical cystectomy.
    Hofner T; Macher-Goeppinger S; Klein C; Schillert A; Eisen C; Wagner S; Rigo-Watermeier T; Baccelli I; Vogel V; Trumpp A; Sprick MR
    Urol Oncol; 2014 Jul; 32(5):678-86. PubMed ID: 24631171
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Repression of mammosphere formation of human breast cancer cells by soy isoflavone genistein and blueberry polyphenolic acids suggests diet-mediated targeting of cancer stem-like/progenitor cells.
    Montales MT; Rahal OM; Kang J; Rogers TJ; Prior RL; Wu X; Simmen RC
    Carcinogenesis; 2012 Mar; 33(3):652-60. PubMed ID: 22219179
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Proteolysis-a characteristic of tumor-initiating cells in murine metastatic breast cancer.
    Hillebrand LE; Bengsch F; Hochrein J; Hülsdünker J; Bender J; Follo M; Busch H; Boerries M; Reinheckel T
    Oncotarget; 2016 Sep; 7(36):58244-58260. PubMed ID: 27542270
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Ink4a/Arf(-/-) and HRAS(G12V) transform mouse mammary cells into triple-negative breast cancer containing tumorigenic CD49f(-) quiescent cells.
    Kai K; Iwamoto T; Kobayashi T; Arima Y; Takamoto Y; Ohnishi N; Bartholomeusz C; Horii R; Akiyama F; Hortobagyi GN; Pusztai L; Saya H; Ueno NT
    Oncogene; 2014 Jan; 33(4):440-8. PubMed ID: 23376849
    [TBL] [Abstract][Full Text] [Related]  

  • 53. miR-7 suppresses brain metastasis of breast cancer stem-like cells by modulating KLF4.
    Okuda H; Xing F; Pandey PR; Sharma S; Watabe M; Pai SK; Mo YY; Iiizumi-Gairani M; Hirota S; Liu Y; Wu K; Pochampally R; Watabe K
    Cancer Res; 2013 Feb; 73(4):1434-44. PubMed ID: 23384942
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Established breast cancer stem cell markers do not correlate with in vivo tumorigenicity of tumor-initiating cells.
    Lehmann C; Jobs G; Thomas M; Burtscher H; Kubbies M
    Int J Oncol; 2012 Dec; 41(6):1932-42. PubMed ID: 23042145
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Invading basement membrane matrix is sufficient for MDA-MB-231 breast cancer cells to develop a stable in vivo metastatic phenotype.
    Abdelkarim M; Vintonenko N; Starzec A; Robles A; Aubert J; Martin ML; Mourah S; Podgorniak MP; Rodrigues-Ferreira S; Nahmias C; Couraud PO; Doliger C; Sainte-Catherine O; Peyri N; Chen L; Mariau J; Etienne M; Perret GY; Crepin M; Poyet JL; Khatib AM; Di Benedetto M
    PLoS One; 2011; 6(8):e23334. PubMed ID: 21858074
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Ethnicity-Dependent and -Independent Heterogeneity in Healthy Normal Breast Hierarchy Impacts Tumor Characterization.
    Nakshatri H; Anjanappa M; Bhat-Nakshatri P
    Sci Rep; 2015 Aug; 5():13526. PubMed ID: 26311223
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Genetic profiling of putative breast cancer stem cells from malignant pleural effusions.
    Tiran V; Stanzer S; Heitzer E; Meilinger M; Rossmann C; Lax S; Tsybrovskyy O; Dandachi N; Balic M
    PLoS One; 2017; 12(4):e0175223. PubMed ID: 28423035
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Detection of minor subpopulations of colorectal adenocarcinoma cells expressing cancer stem cell markers.
    Gisina AM; Lupatov AY; Karalkin PA; Mainovskaya OA; Petrov LO; Sidorov DV; Yarygin VN; Yarygin KN
    Bull Exp Biol Med; 2011 Jun; 151(2):234-8. PubMed ID: 22238758
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Gene Knockdown by EpCAM Aptamer-siRNA Chimeras Suppresses Epithelial Breast Cancers and Their Tumor-Initiating Cells.
    Gilboa-Geffen A; Hamar P; Le MT; Wheeler LA; Trifonova R; Petrocca F; Wittrup A; Lieberman J
    Mol Cancer Ther; 2015 Oct; 14(10):2279-91. PubMed ID: 26264278
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Regulator of G-protein signalling 2 mRNA is differentially expressed in mammary epithelial subpopulations and over-expressed in the majority of breast cancers.
    Smalley MJ; Iravani M; Leao M; Grigoriadis A; Kendrick H; Dexter T; Fenwick K; Regan JL; Britt K; McDonald S; Lord CJ; Mackay A; Ashworth A
    Breast Cancer Res; 2007; 9(6):R85. PubMed ID: 18067675
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.